cinqair

Generic: reslizumab

Labeler: teva respiratory, llc
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name cinqair
Generic Name reslizumab
Labeler teva respiratory, llc
Dosage Form INJECTION, SOLUTION, CONCENTRATE
Routes
INTRAVENOUS
Active Ingredients

reslizumab 10 mg/mL

Manufacturer
Teva Respiratory, LLC

Identifiers & Regulatory

Product NDC 59310-610
Product ID 59310-610_a6e253d0-2741-4a06-afa7-e3bd866b64ec
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761033
Listing Expiration 2026-12-31
Marketing Start 2016-04-18

Pharmacologic Class

Established (EPC)
interleukin-5 antagonist [epc]
Mechanism of Action
interleukin-5 antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 59310610
Hyphenated Format 59310-610

Supplemental Identifiers

RxCUI
1746893 1746898
UNII
35A26E427H
NUI
N0000191872 N0000191871

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cinqair (source: ndc)
Generic Name reslizumab (source: ndc)
Application Number BLA761033 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 10 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-USE in 1 CARTON (59310-610-31) / 10 mL in 1 VIAL, SINGLE-USE
  • 1 VIAL, SINGLE-USE in 1 CARTON (59310-610-33) / 10 mL in 1 VIAL, SINGLE-USE
source: ndc

Packages (2)

Ingredients (1)

reslizumab (10 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "a6e253d0-2741-4a06-afa7-e3bd866b64ec", "openfda": {"nui": ["N0000191872", "N0000191871"], "unii": ["35A26E427H"], "rxcui": ["1746893", "1746898"], "spl_set_id": ["053b9158-2a5b-48b9-bf47-5fa78a35ec33"], "pharm_class_epc": ["Interleukin-5 Antagonist [EPC]"], "pharm_class_moa": ["Interleukin-5 Antagonists [MoA]"], "manufacturer_name": ["Teva Respiratory, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (59310-610-31)  / 10 mL in 1 VIAL, SINGLE-USE", "package_ndc": "59310-610-31", "marketing_start_date": "20160418"}, {"sample": true, "description": "1 VIAL, SINGLE-USE in 1 CARTON (59310-610-33)  / 10 mL in 1 VIAL, SINGLE-USE", "package_ndc": "59310-610-33", "marketing_start_date": "20170604"}], "brand_name": "CINQAIR", "product_id": "59310-610_a6e253d0-2741-4a06-afa7-e3bd866b64ec", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "pharm_class": ["Interleukin-5 Antagonist [EPC]", "Interleukin-5 Antagonists [MoA]"], "product_ndc": "59310-610", "generic_name": "Reslizumab", "labeler_name": "Teva Respiratory, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CINQAIR", "active_ingredients": [{"name": "RESLIZUMAB", "strength": "10 mg/mL"}], "application_number": "BLA761033", "marketing_category": "BLA", "marketing_start_date": "20160418", "listing_expiration_date": "20261231"}